SEC Filings / Submissions

Year
Form Type
Date SUBMISSION Description Download
29/07/2024 6-K SHL Telemedicine to appoint David Arnon as CEO of SHL Telemedicine
25/07/2024 20-F/A Amendment No. 1 on Form 20-F/A – Annual Report
20/06/2024 6-K SHL Telemedicine confirms discussions regarding a possible investment in its Israeli activity
09/05/2024 6-K SHL announces Special General Meeting Results
18/04/2024 20-F  Form 20-F
17/04/2024 6-K SHL Telemedicine Ltd Announces the filing of Full-Year 2023 Results
26/03/2024 6-K Notice and Proxy Statement for the Special General Meeting
14/03/2024 6-K SHL announces change in CEO position
08/02/2024 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION